Minted: - / 5000

1133 Panomifene
4da498bd0ef01c48214810705a99c3829dc6bceaa57f84b5330308d2b3ed2c7f

Properties

Background

Green
Bottle

Green
Cap

Red
Syringe

Gray
Bubbles
No
Drops
No
Label
Pill

Chemistry

Formula
C25H24F3NO2
Carbon
25
Polarity
Neutral

Panomifene (INN; developmental codes GYKI 13504 and EGIS 5650) is a nonsteroidal selective estrogen receptor modulator (SERM) of the triphenylethylene group related to tamoxifen that was under development as an antineoplastic agent by Egis Pharmaceuticals and IVAX Drug Research Institute in the 1990s for the treatment of breast cancer, but it was never marketed. It reached phase II clinical trials before development was terminated. The drug was described in 1981.

From Wikipedia, the free encyclopedia. License: CC BY-SA.